{"id":248270,"date":"2018-07-31T18:56:08","date_gmt":"2018-07-31T18:56:08","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=248270"},"modified":"2018-07-31T18:56:08","modified_gmt":"2018-07-31T18:56:08","slug":"antinuclear-antibody-ana-test-market-research-2018-rising-medical-insurance-alere-inc-biorad-laboratories-thermo-fisher-scientific-trinity-biotech-antibodies-incorporated-euroimmun-ag","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/antinuclear-antibody-ana-test-market-research-2018-rising-medical-insurance-alere-inc-biorad-laboratories-thermo-fisher-scientific-trinity-biotech-antibodies-incorporated-euroimmun-ag_248270.html","title":{"rendered":"Anti-Nuclear Antibody (ANA) Test Market Research 2018 Rising Medical Insurance: Alere Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Trinity Biotech, Antibodies Incorporated, EUROIMMUN AG"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/07\/1533031086.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/07\/1533031086.jpeg\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Global Anti-Nuclear Antibody Test Market is expected to reach USD 1,964.47 million by 2025 from USD 1,093.40 million in 2017, at a CAGR of 7.7% in the forecast period 2018 to 2025.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">databridgemarketresearch.com Adds \u201cGlobal Anti-Nuclear Antibody Test Market Trends, Size, Type, Share, Outlook, Growth, Overview, Key Players and Forecast to 2018-2025\u201d To Its Research Database.<\/div>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/databridgemarketresearch.com\/reports\/global-antinuclear-antibody-test-market\/\" target=\"_blank\">Anti-nuclear Antibody Test Market&nbsp;<\/a>2018 Industry report gives a brief summary of definitions, applications, types and leading key players\/manufacturers of&nbsp;Anti-nuclear Antibody Test&nbsp;industry. It provides complete, professional, and extensive analysis of Anti-nuclear Antibody Test Market.&nbsp;<\/p>\n<p style=\"text-align: justify;\">Global Anti-Nuclear Antibody Test Market is expected to reach USD 1,964.47 million by 2025 from USD 1,093.40 million in 2017, at a CAGR of 7.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.<\/p>\n<p style=\"text-align: justify;\"><strong>Here is the Solution! Click Here For Free Sample Report @: <\/strong><a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/request-a-sample\/?dbmr=global-antinuclear-antibody-test-market\"><strong>http:\/\/databridgemarketresearch.com\/request-a-sample\/?dbmr=global-antinuclear-antibody-test-market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">Antinuclear Antibody Test Market Analysis Report contains all Analytical and Statistical brief about Market Overview, Growth, Demand and Forecast Research. This Antinuclear Antibody Test Market report offers some searching overview and solution in the complex world of Antinuclear Antibody Test Industry.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the Major Players Operating in this Market are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Bio-Rad Laboratories Inc.,<\/li>\n<li>Alere,<\/li>\n<li>Trinity Biotech,<\/li>\n<li>Thermo Fisher Scientific Inc.,<\/li>\n<li>Antibodies Inc.,<\/li>\n<li>EUROIMMUN AG, and<\/li>\n<li>Immuno Concepts among others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Autoimmune disease is a condition in which the immune system attacks the body. The major role of the immune system is to guard us against foreign invaders like germs and bacteria. In normal conditions the immune system can differentiate between normal cells and foreign cells but in case of autoimmune disease, it releases proteins called antibodies that attack the healthy cells. Some of the most common autoimmune diseases are: Rheumatoid arthritis, Type 1 diabetes, Systemic lupus erythematosus, Multiple sclerosis, Graves&rsquo; disease, Addison&rsquo;s disease, inflammatory bowel disease, Sj&ouml;gren&rsquo;s syndrome, Myasthenia gravis, Celiac disease, Vasculitis.<\/p>\n<p style=\"text-align: justify;\">The increasing number of autoimmune diseases requires more number of ANA tests to be performed for the diagnosis. With the rising number of diagnostic tests, demand of ANA test kits and other products are also increasing which is ultimately boosting the market to grow.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Any Specific Requirements? Questions? Ask to Our Industry <\/strong><strong>Expert @&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/databridgemarketresearch.com\/inquire-before-buying\/?dbmr=global-antinuclear-antibody-test-market\" target=\"_blank\">https:\/\/databridgemarketresearch.com\/inquire-before-buying\/?dbmr=global-antinuclear-antibody-test-market<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>TABLE OF CONTENTS GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>1. INTRODUCTION<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>2. MARKET SEGMENTATION<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3. MARKET OVERVIEW<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3.1. DRIVERS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3.2. RESTRAINTS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3.3. OPPORTUNITIES<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>3.4. CHALLENGES<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>4. EXECUTIVE SUMMARY<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>5. PREMIUM INSIGHTS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY PRODUCT<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6.1. OVERVIEW<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6.2. ASSAY KITS &amp; REAGENTS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6.3. SYSTEMS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>6.4. SOFTWARE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY TEST<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7.1. OVERVIEW<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7.2. INDIRECT IMMUNOFLUORESCENCE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7.3. ELISA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>7.4. MULTIPLEX TESTING<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY DISEASE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.1. OVERVIEW<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.2. RHEUMATOID ARTHRITIS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.3. SYSTEMIC LUPUS ERYTHEMATOSUS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.4. SJ&Ouml;GREN&rsquo;S SYNDROME<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.5. SCLERODERMA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.6. POLYMYOSITIS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>8.7. OTHERS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY END USER<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9.1. OVERVIEW<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9.2. HOSPITALS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9.3. CLINICS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9.4. PHYSICIAN OFFICE LABORATORIES<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>9.5. OTHERS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, BY GEOGRAPHY<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.1. OVERVIEW<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>10.2. NORTH AMERICA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.2.1. U.S.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.2.2. CANADA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.2.3. MEXICO<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>10.3. EUROPE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.1. GERMANY<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.2. FRANCE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.3. U.K.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.4. ITALY<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.5. SPAIN<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.6. SWITZERLAND<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.7. NETHERLANDS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.8. BELGIUM<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.9. RUSSIA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.10. TURKEY<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.3.11. REST OF EUROPE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4. ASIA-PACIFIC<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.1. CHINA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.2. JAPAN<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.3. INDIA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.4. SOUTH KOREA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.5. AUSTRALIA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.6. SINGAPORE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.7. THAILAND<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.8. MALAYSIA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.9. INDONESIA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.10. PHILIPPINES<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.4.11. REST OF ASIA-PACIFIC<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.5. SOUTH AMERICA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.5.1. BRAZIL<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.5.2. REST OF SOUTH AMERICA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>10.6. MIDDLE EAST &amp; AFRICA<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>11. GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET, COMPANY LANDSCAPE<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12. COMPANY PROFILES<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.1. THERMO FISHER SCIENTIFIC INC.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.2. MERCK KGAA<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.3. ALERE INC.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.4. TRINITY BIOTECH<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.5. ANTIBODIES INC.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.6. BIO-RAD LABORATORIES, INC.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.7. EUROIMMUN AG (A SUBSIDIARY OF PERKINELMER INC.)<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>12.8. IMMUNO CONCEPTS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>13. RELATED REPORTS<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Questions? We&rsquo;ll Put You On The Right Path Request Analyst Call<strong> @ <\/strong><\/strong><a rel=\"nofollow\" href=\"http:\/\/databridgemarketresearch.com\/speak-to-analyst\/?dbmr=global-antinuclear-antibody-test-market\"><strong>http:\/\/databridgemarketresearch.com\/speak-to-analyst\/?dbmr=global-antinuclear-antibody-test-market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Related Report <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Global Molecular Spectroscopy Market &ndash; Industry Trends and Forecast to 2024<\/strong><\/p>\n<p style=\"text-align: justify;\">Global Molecular Spectroscopy Market, By Type (Nuclear Magnetic Resonance (Continuous Wave, Fourier Transform, Solid State), UV-Vis, Infrared (IR), Near Infrared (NIR), Colour Spectroscopy, Raman Spectroscopy, Others), By Applications (Pharmaceuticals, Biotech, Food and Beverages, Environmental Testing, Academics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) &ndash; Industry Trends and Forecast to 2024<\/p>\n<p style=\"text-align: justify;\">http:\/\/databridgemarketresearch.com\/reports\/global-molecular-spectroscopy-market\/<\/p>\n<p style=\"text-align: justify;\"><strong>About Data Bridge Market Research:<\/strong><\/p>\n<p style=\"text-align: justify;\">Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.<\/p>\n<p style=\"text-align: justify;\"><strong>Contact: <\/strong><\/p>\n<p style=\"text-align: justify;\">Vishal Dixit<\/p>\n<p style=\"text-align: justify;\">Data Bridge Market Research<\/p>\n<p style=\"text-align: justify;\">Tel: +1-888-387-2818<\/p>\n<p style=\"text-align: justify;\">Email: sopan.gedam@databridgemarketresearch.com<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Data Bridge Market Research Private Limited<br \/><strong>Contact Person:<\/strong> Sopan Gedam<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=antinuclear-antibody-ana-test-market-research-2018-rising-medical-insurance-alere-inc-biorad-laboratories-thermo-fisher-scientific-trinity-biotech-antibodies-incorporated-euroimmun-ag&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1-888-387-2818<br \/><strong>Address:<\/strong>Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar  <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"https:\/\/databridgemarketresearch.com\/reports\/global-antinuclear-antibody-test-market\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/databridgemarketresearch.com\/reports\/global-antinuclear-antibody-test-market\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/databridgemarketresearch.com\/reports\/global-antinuclear-antibody-test-market\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=antinuclear-antibody-ana-test-market-research-2018-rising-medical-insurance-alere-inc-biorad-laboratories-thermo-fisher-scientific-trinity-biotech-antibodies-incorporated-euroimmun-ag\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Global Anti-Nuclear Antibody Test Market is expected to reach USD 1,964.47 million by 2025 from USD 1,093.40 million in 2017, at a CAGR of 7.7% in the forecast period 2018 to 2025.&#8221; databridgemarketresearch.com Adds \u201cGlobal Anti-Nuclear Antibody Test Market Trends, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/antinuclear-antibody-ana-test-market-research-2018-rising-medical-insurance-alere-inc-biorad-laboratories-thermo-fisher-scientific-trinity-biotech-antibodies-incorporated-euroimmun-ag_248270.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-248270","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/248270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=248270"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/248270\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=248270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=248270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=248270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}